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Objectives: Apical aneurysms in patients with hypertrophic cardiomyopathy (HCM) represent
an underrecognized but clinically important subset of HCM patients. However it may be
frequentlymissed by echocardiography because of poor imagequality of left ventricular apex.
We aimed to compare electrocardiographic STE in HCM patients with and without apical
aneurysm.
Methods: We developed this clinical review using an extensive MEDLINE review of the
literature and data from our laboratories; and some electrocardiographic parameters in-
cluding STE were analysed in HCM patients with and without apical aneurysm.
Results: There were 29 HCM patients without apical aneurysm (Group 1; 52.6  17.7years,
69%male) and 28 HCM patients with apical aneurysm (Group 2; 59.6  13.2years, 57%male).
The STE in V4-6 derivations were statistically more frequent in patients with apical aneu-
rysm compared to those without aneurysm (93% vs 7%, p < 0.001). There was a positive
correlation between the presence of the STE in V4-6 derivations and the presence of the
apical aneurysm (Spearman's r = 0.895, p < 0.001).
Conclusions: Clinicians and speciﬁcally echocardiographers must pay special attention on
the electrocardiography to correctly detect the frequently overlooked apical aneurysm in
HCM patients, and should be careful for apical aneurysm particularly in the presence of STE
in V4-6 derivations.
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of HCM occur that spare the proximal septum: patients
with the apical hypertrophic cardiomyopathy (ACM) and
mid-ventricular obstructive hypertrophic cardiomyopathy
(MVO-HCM).
Apical aneurysms in patients with HCM represent an
underrecognized but clinically important subset of HCM
patients, often requiring a high index of suspicion, have been
found to be associated with both ACM and MVO-HCM
variants.2–6 It has been reported that 10–25% incidence of
all patients presenting with ACM or MVO-HCM subsequently
develop apical aneurysms.2–7Whereas the reported preva-
lance is 2%,2,5 a previous study reported the incidence of
concealed apical aneurysm with MVO-HCM to be approxi-
mately 1.5% of all HCM cases.4 Although the electrocardio-
gram and transthoracic echocardiography are the two most
useful measures for the diagnosis of HCM,3,8,9 diagnostic
limitations of echocardiography primarily due to poor image
quality of the left ventricular apex or due to apical
foreshortening on planar imaging may cause misdiagnosis
between the ACM and MVO-HCM variants, particularly in the
presence of an undetected apical aneurysm.2–6,8,10 Previous
descriptions of an association of apical aneurysm with ST
segment elevation (STE) have been conﬁned to small patient
series. Therefore, we aim to provide some electrocar-
diographic clues to help differentiating between HCM
patients with and without apical aneurysm.
2. Method[(Fig._1)TD$FIG]
Fig. 1 – Electrocardiograms showing the three different ST
segment changes in V4-6 leads as a depressed ST segment
(A), an isoelectric ST segment (B), or an elevated ST
segment (C).Patients, admitted to our hospitals due to electrocar-
diographic abnormalities or clinical symptoms and diag-
nosed consecutively as having ACMwithout apical aneurysm
(Group 1) included study. Since MVO-HCM patients with
apical aneurysm (Group 2) were rare in our databases, a
subsequent PubMed search was conducted using the terms
‘‘hypertrophic cardiomyopathy,’’ ‘‘midventricular obstruc-
tion’’ ‘‘apical aneurysm,’’ or ‘‘apical diverticule’’ ‘‘apical
pouch’’, or ‘‘apical outpouching’’. The search was limited to
English language articles published between January 1976
and January 2013. The clinical, electrocardiographic, echo-
cardiographic, left ventriculographic (Video 1 and 2) or CMR
data were collected.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.ihj.2015.05.019.
By means of two-dimensional echocardiography, patients
were diagnosed as having ACMwhen they had left ventricular
hypertrophy of wall thickness >15 mm predominantly local-
ized to the left ventricular apex partially or wholly along the
circumference, with the ratio ofmaximal apical wall thickness
to basal posterior wall thickness being>1.5.1,2 Left ventricular
MVO-HCM was diagnosed when midventricular obliteration
was caused bymarked septal hypertrophy resulting in contact
with a hypercontractile left ventricular freewall rather than by
sytolic anterior motion of the anterior mitral valve leaﬂet.2 A
left ventricular apical aneurysm was deﬁned as a discrete,
thin-walled dyskinetic or akinetic segment of the most distal
portion of the chamber with a relatively wide communication
to the left ventricular cavity.4Bymeans of 12-lead electrocardiography, wemeasured the
maximal voltage of negative T-wave in V3 to V6 leads, the
voltage of S-wave in V1 and the maximal R-wave in V3 to V6.
We also evaluated STE and T wave inversions in all leads.
Repolarization abnormalities were deﬁned by ST-segment
elevation or depression 0.1 mV above or below the baseline at
0.08 s after the J point and T-wave inversion [Fig. 1, depressed
ST segment (A), isoelectric ST segment (B), elevated ST
segment (C)]
The patients were excluded, if: (i) they had poor quality
ECG tracings (ii) they had an obstructive atherosclerotic
coronary artery disease as a cause of apical aneurysm
formation, or (iii) they had signiﬁcant missing echo and
CMR in their report.
The SPSS statistical software package (version 16.0; SPSS
Inc, Chicago, Ill) was used to perform all statistical calcula-
tions. Continuous variableswere expressed asmean  SD, and
compared using the Mann–Whitney U test. Categorical
variables were expressed as numbers and percentages, and
compared using the Chi2test. Relationships between the
categorical variables were evaluated Spearman's correlation
analysis. For all tests, a value of p < 0.05 was considered
signiﬁcant.
3. ResultsThere were 29 HCM patients without apical aneurysm (Group
1; 52.6  17.7 years, 69%male) and 28 HCMpatients with apical
aneurysm (Group 2; 59.6  13.2years, 65% male). The clinical
and electrocardiographic characteristics of the HCM patients
with and without apical aneurysm were summarized in
Table 1.
Table 1 – Basal demographic and clinical characteristics features, and the comparison of electrocardiographic findings in
HCM patients with and without apical aneurysm.
Group 1 (apical aneurysm -)
(n = 29)
Group 2 (apical aneurysm +)
(n = 28)
p Value
Demographic Features
Age at diagnosis (year; median-IQR) 55.0 (22) 56.5 (20) 0.13
Gender (male, %) 20/29 (69) 16/28 (57) 0.36
Asymptomatic (%) 10/29 (34) 6/28 (21) 0.27
Palpitation (%) 6/29 (21) 14/28 (50) 0.02
Chest pain (%) 15/29 (52) 10/28 (36) 0.22
Nonsustained VT (%) 2/29 (7) 7/28 (25) 0.06
VT/VF (%) 3/29 (10) 7/28 (25) 0.23
Syncope (%) 6/29 (21) 8/28 (27) 0.49
Thrombus in apical cavity (%) 0/29 (0) 7/28 (25) 0.02
TIA/CVA (%) 2/29 (7) 1/28 (4) 0.57
Electrocardiographic Findings
SV1 (mV; median – IQR) 10.5 (10) 12.0 (5) 0.70
Max negative T-wave in V3-6 (mV; median) 9.5 (9) 5.0 (5) 0.001
Max R-wave in V3-6 (mV; median-IQR) 23.0 (15) 17.0 (9) 0.001
Negative T-wave (%) in 2-3-aVF 26/29 (90) 23/28 (82) 0.41
Negative T-wave (%) in V4-6 29/29 (100) 27/28 (96) 0.31
Negative T-wave (%) in 1-aVL 27/29 (93) 25/28 (89) 0.61
STE (%) in 2-3-aVF 2/29 (7) 17/28 (61) <0.001
STE (%) in V4-6 2/29 (7) 26/28 (93) <0.001
ST depression (%) in 2-3-aVF 6/29 (21) 0/28 (0) 0.01
ST depression (%) in V4-6 15/29 (52) 2/28 (7) <0.001
ST depression (%) in 1-aVL 12/29 (41) 4/28 (14) 0.02
IQR, interquartile range; Max, maximum; HCM; hypertrophic cardiomyopathy; VT, ventricular tachycardia; VF, ventricular ﬁbrillation; TIA,
transient ischemic attack; CVA, cerebrovascular accident; STE, ST segment elevation.
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frequent in patients with apical aneurysm compared to those
without aneurysm (93% vs 7%, p < 0.001). There was a positive
correlation between the presence of the STE in V4-6 and the
presence of the apical aneurysm (Spearman's r = 0.895,
p < 0.001).
4. DiscussionWe found that the STE in V4-6 derivations were statistically
more frequent inHCMpatientswithapical aneurysmcompared
to those without aneurysm. This ﬁnding may provide us a
usefull electrocardiographic clue to correctly detect the fre-
quently overlooked apical aneurysm in HCM patients.
The ACM was ﬁrst described in the Japanese population in
1977 by Sakamoto et al as a unique entity characterized by
myocardial hypertrophywith predominant involvement at the
apex, the hallmarks of giant negative T waves (>10 mm) in the
left precordial leads, and angiographic spade-shaped appear-
ance of the left ventricular cavity (Fig. 2A).8 Despite its
relatively good prognosis,7 long-term observations occasion-
ally exhibited gradual progression of cardiac hypertrophy and
apical aneurysm, but often presents a diagnostic challenge.2,4,5
The other rare variant of MVO-HCM, which was ﬁrst reported
by Falicov et al in 1976, is characterized by the presence of
pressure gradient between the apical and basal chambers of
the left ventricle, and is also frequently associated with an
apical aneurysm without signiﬁcant atherosclerotic coronary
artery disease.11
Classically left ventricular apical aneurysm has been
considered a complication of acute myocardial infarction,but also has been reported as associated with HCM, Chagas'
disease, sarcoidosis, congenital or idiopathic.12 In most cases,
the chronic apical aneurysm in the presence of the previous
myocardial infarction manifested electrocardiographically by
varying degrees of chronic STE.12 Although ACM is often a
relatively benign disease compared to obstructive HCM, the
HCM patients with apical aneurysms have been noted to have
a higher risk of systemic emboli due to apical intracavitary
thrombus formation, ventricular tachyarrhythmias, sudden
cardiac death (SCD) and perfusion defects on nuclear stress
testing.13 Therefore, deﬁnitive noninvasive diagnosis of ACM
with or without apical aneurysm has some diagnostic and
therapeutic implications.13,14 Currently, the cardiovascular
magnetic resonance imaging (CMR) is generally regarded as
the gold-standard diagnostic test for HCM particularly in
challenging HCM cases15,16; however, it is not commonly used
in daily practice.
Since it has found to be associated with a higher risk of
systemic emboli due to apical intracavitary thrombus forma-
tion and SCD related to ventricular tachyarrhythmias,5,17 the
recognition of an apical aneurysm in patients with HCM is
important for diagnosis, therapeutic approaches and prog-
nostic evaluation. It has been reported that HCM patients with
large apical aneurysms (>4 cm diameter) are more likely to
experience adverse disease complications than patients with
small aneurysms (<4 cm diameter).5 Again, the ventricular
arrhythmia has been originated from the neck of the apical
aneurysm and the associated extensive areas of myocardial
ﬁbrosis, which have been regarded as arrhythmogenic sub-
strates for the generation of malignant ventricular tachyar-
rhythmias.18 It is therefore not surprising that the majority of
reported HCM related events in patients with MVO-HCM with
[(Fig._2)TD$FIG]
Fig. 2 – An example of hypertrophic cardiomyopathy patient with easily missed apical aneurysm diagnosis. Left
ventriculogram showing the ace of spades configuration suggesting the apical hypertrophic cardiomyopathy without apical
aneurysm (A); however, the left ventriculogram from the apical segment taken from the same patient showing the true apical
aneurysm (B). This patient has an inferolateral T wave inversion with ‘‘ST elevation’’ on electrocardiogram (C).
Echocardiogram showing a diastolic paradoxic jet flow (arrow) across the obliterated left ventricular apex toward the base (D).
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mias.3,4,19 However, the management of this subset of HCM
is controversial, in part because patientsmay range frombeing
asymptomatic to having life-threatening ventricular arrhyth-
mias and SCD. Some authors report that the ventricular
arrhythmias complicated with left ventricular apical aneu-
rysm cannot be easily suppressed by medication, and suggest
that a more-aggressive therapeutic approach, including
medication, implantable cardioverter-deﬁbrillator placement,
cryoablation at the rim of the aneurysm and surgery by
complete excision of the scar tissue and obliteration of the
aneurysmal pouch to prevent SCD in selected patients with
large or thin-walled aneurysms, must be considered.20,21 On
the other hand, others do not recommend prophylactic
surgical resection despite the marked thinning of the aneu-
rysmwall due to low risk of ventricular rupture.5 In addition to
arrhythmic features, cerebrovascular events also have been
found to be frequent in this subset of HCM.5 Therefore,
presence of an apical aneurysm in a patient with HCMmust be
evaluated.
Echocardiography is themost commondiagnostic tool used
to evaluate themorphologic and functional features of HCM,22but has some limitations particularly in apical variants. Some
echocardiographers miss the diagnosis of apical thickening if
the apex is not clearly seen, or if a thickened apex is mistaken
for apical foreshortening on planar imaging, necessitating the
use of CMR modality23 or contrast echocardiography24 in
patients in whom initial echocardiographic studies are
nondiagnostic.25Even with left ventriculogram, the apical
aneurysm could be missed (Fig 2A) unless it could not
performed within the aneurysm (Fig 2B). In the presence of
MVO, there is a signiﬁcant intraventricular pressure gradient
between the apex and the main left ventricular cavity. This
systolic gradient, sometimes associated with a diastolic
paradoxic jet ﬂow on echocardiography (Fig. 2D, Video 3),4,26
indicates the existence of a discrete apical chamber or a true
apical aneurysm.10,17 However, this diastolic paradoxical jet
ﬂow across the obliterated left ventricular apex toward the
base can not always be detected by transthoracic echocardi-
ography. In one study, it was present in 10% of patients with
HCM.26 Moreover, the intraventricular pressure gradients are
present at rest in only one third of apical aneurysm patients.5
For these reasons, there are reports of challenging clinical and
surgical cases in literature due to overlooked or misdiagnosed
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 4 3 4 – 4 3 9438cases particularly between the MVO-HCM and ACM with a
small non-obliterated area in ACM.2,3,10,27
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.ihj.2015.05.019.
Although echocardiographic image enhancement with an
intravenous contrast agent24 and CMR23 have been shown to
improve the visualization of the endocardial–blood interface,
clinical attention must be drawn to the unique electrocar-
diographic features that provide the initial clues tomaking the
diagnosis. In present study, we found that STE in V4-6
derivations in addition to classically giant T wave inversion
were well correlated with the presence of apical aneurysm in
HCMpatients. Asmany as half of patientswith ACMaremildly
symptomatic or asymptomatic, and many patients have been
diagnosed only when giant negative T waves in the left
precordial leads are noted incidentally on ECG.8,23 However, it
is also reported that this giant negative T wavesmay evolve in
both positive and negative directions over time.9,28 Transition
from normal T waves to negative T waves can occur acutely or
this process can take several years and usually remains
unchanged thereafter. On the other hand, the disappearance
of negative Twavesmay also occur slowly andprogressively in
patients, in whom apical aneurysm had developed.8,9 Inves-
tigators have suggested that the progression of myocardial
disease in the left ventricular apex could be a mechanism for
the disappearance of negative T waves. However, the precise
mechanism for these electrocardiographic changes remains to
be determined. Themechanisms contributing to the formation
of apical aneurysms in HCM are multiple and still to be
clariﬁed. Possible causes include the increased afterload and
high apical pressure, ventricular remodeling, the increased
oxygen demand due to increased myocardial thickness and
decreased oxygen supply due to the decreased capillary
network and apical myocardial infarction.3,29 Maron et al
showed that ST-T abnormalities were more prevalent in the
patients with the involvement of substantial portions of both
the ventricular septum and anterolateral LV free wall than in
those with the isolated involvement of the anterior septum,
posterior septum, or apical region.30 They also reported that,
13 patient had the initial convex STE with negative T waves in
lateral leads among the 28 apical aneurysm patients.5 There
were only two patientswho had an STE in V4-6without having
apical aneurysm in literature31,32; however, one of themhas no
CMR data, so a conclusion about the absence of an aneurysm
can not be made deﬁnitively. Similar to dynamic T wave
changes associated with formation of apical aneurysm, some
reported that STE during follow-up of HCM patients has also
been associated with the development of an apical aneu-
rysm.14,33 In another case report, transformation of previous
STdepression to ST segmentnormalizationwith concomitant
disappearance of negative T wave was reported to be
associated with the development of an apical aneurysm.
Currently available studies report controversial results
regarding resting ECG ﬁndings and prognosis in HCM.
Haghjoo et al has reported ST-segment depression in the
high lateral leads to be of prognostic signiﬁcance in HCM
patients in addition to generally accepted risk factors.34
Furushima et al reported that the electrical storm was more
common in patientswith STE in precordial leadsV4–V6,18 and
Maron et al reported that more than 40% of the HCM patientswith an apical aneurysm presented with bursts of nonsus-
tained monomorphic ventricular tachycardia on Holter
electrocardiograpy.5
In conclusion, the 12-lead electrocardiography has tradi-
tionally been an integral part of the non-invasive evaluation of
HCM patients. Clinicians and speciﬁcally echocardiographers
must pay special attention on the electrocardiography to
correctly detect the frequently overlooked apical aneurysm in
HCMpatients, and should be careful for apical aneurysm in the
presence of STE in V4-6 derivations. This may be particularly
useful when the left ventricular apical characteristics are not
clearly deﬁned due to technical challanges during basic
transthoracic echocardiography.
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